Edition 10: Drug-resistant TB

Edition 10: Drug-resistant TB

Interactive Data Dashboards

Track the HIV & TB response

Live indicators, province breakdowns and downloadable data.

  • In-depth: New resistance tests set to improve TB treatment

    Tuberculosis (TB) can be resistant to treatment with several different drugs. Tests that identify which drugs someone’s TB is resistant to are critical to ensuring that people are not treated with drugs that don’t work for them, especially given the significant side effects associated with some of the drugs. Elri Voigt assesses the state of…

    ·

  • TB treatment can be cut to two months for some, finds landmark study

    Some cases of tuberculosis (TB) can be successfully treated in as little as two months – a third of the current standard of six months. This is according to early findings from the landmark TRUNCATE TB trial presented at last week’s Union World Conference on Lung Health. Elri Voigt reports.

    ·

  • Are long-acting injections the future of TB prevention?

    Long-acting injections have been successfully used as contraception and more recently HIV prevention. Now researchers are exploring whether similar long-acting injections could be used for the prevention and treatment of tuberculosis. Tiyese Jeranji reports.

    ·

  • Opinion: It is time to invest in ending TB in SA

    Investing in tuberculosis means that everyone has a stake in eliminating TB as a public health threat in our country: every person, every family, every community, every organisation (public and private) as well as government, writes Dr Yogan Pillay and Gaurang Tanna.

    ·

  • PROFILE: I view the doctor-patient relationship as sacred, says leading TB doctor

    Dr Jennifer Furin has fought drug-resistant tuberculosis (TB) since 1995, when she worked as a student in a poverty-stricken suburb in Lima, Peru. Since then she has roamed the world, treating TB and HIV patients in under-resourced countries, including Haiti, Russia, Tajikistan, Bangladesh, eSwatini, Lesotho, and South Africa. Biénne Huisman chatted to Furin about her…

    ·

  • Good and bad news about new TB vaccines

    While there are nine experimental tuberculosis (TB) vaccines in advanced trials, the vaccine pipeline beyond those nine prospects is relatively depleted. Adele Baleta reports on this and much more from the virtual Global TB Vaccine Forum held last week.

    ·

  • Fingerstick blood test shows promise for TB screening

    The World Health Organization estimates that over four million of the almost ten million people who fell ill with tuberculosis in 2020 were not diagnosed. One obstacle to more people being diagnosed is the fact that most current tests require people to produce sputum – something children and some people living with HIV find difficult.…

    ·

  • Important TB drug as effective at lower dose, study finds

    The treatment of drug-resistant forms of tuberculosis has been transformed over the last decade with treatment becoming more effective, safer, and treatment duration in many cases dropping to under a year. Even so, treatment can still come with serious side effects and for some, it can still last over a year and a half. In…

    ·

  • Opinion: Six ways clinics can help turn the tide on TB infection

    Six simple interventions are at the heart of how clinics can be part of turning the tide on TB infection. By following a checklist of good practice, clinics can be safer for patients and staff. However, most clinics are failing to implement enough of these measures, putting people at risk of getting TB while waiting…

    ·

  • SA piloting mobile X-rays to improve TB detection

    South Africa’s first National Tuberculosis Prevalence Survey found that many people without TB symptoms nevertheless have TB disease that can be detected using chest X-rays. Accordingly, new mobile X-ray screening programmes are being piloted in a number of provinces. Tiyese Jeranji reports.

    ·

  • 400 people in SA with highly drug-resistant TB to get new three-drug regimen

    Treating highly drug-resistant forms of tuberculosis can take anything from nine to 24 months and patients have to contend with various unpleasant, and sometimes dangerous, side effects. A new six-month regimen made up of just three drugs that will be offered to 400 patients in South Africa might offer a better solution for some. Tiyese…

    ·